Who invested in Kura Oncology?
Kura Oncology's investors include Fidelity, ARCH Venture Partners, Hercules Capital, EcoR1 Capital and Nextech Invest.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$210Mraised across 2 rounds since 2015, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $150M sold, first sale Jan 2024
From a historical funding recordSEC filing: $92M sold, first sale Mar 2015
From Kura Oncology's own website and the SEC filings it signed: 13 on the team.
On the board, as filediHelen Collins
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Kura Oncology's investors include Fidelity, ARCH Venture Partners, Hercules Capital, EcoR1 Capital and Nextech Invest.
Kura Oncology has raised $210M across 2 rounds since 2015.
Kura Oncology's most recent round was an Undisclosed round of $150M in Jan 2024.
Its most recent round, $150M in Jan 2024, is also its largest on record.
Kura Oncology's first round on record, in Mar 2015, was backed by Fidelity, ARCH Venture Partners and EcoR1 Capital and 1 others.
Kura Oncology's latest named round is an Undisclosed round, in Jan 2024.
Kura Oncology is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.